Vertex & JDRF

Moving the Needle on Type 1 Diabetes Research

Vertex Pharmaceuticals was honored by the Juvenile Diabetes Foundation in 2022 for their work to advance therapies for type 1 diabetes. This video speaks to Vertex’s entry into the T1D space and the importance of their relationship with JDRF and the wider T1D community.

Client: Vertex Pharmaceuticals